In this webinar, Dr. Emma Gibbin-Lameira will show how Nanolive’s label-free, non-invasive imaging can be used to quantify dose-dependent responses of HeLa cells to Chloroquine.
Specifically, Dr. Gibbin-Lameira will show that:
- Dose-dependent experiments can be performed in 96-well plate format over long periods of time (> 2 days), reducing the need for time and labor-intensive multiple fixed-point measurements and eliminating cytotoxic/cytostatic effects arising from the use of labels, dyes, or phototoxic damage
- Metrics output from Nanolive’s proprietary software, EVE Analytics, can be used to generate statistically robust time-dependent EC50 values based on total dry mass; a metric unique to label-free imaging
- Sub-cellular spatial resolution combined with high content image analysis can be used to investigate a drugs’ mechanism of action
Please register below to watch the webinar on-demand.
Read our latest news
Nanolive launches the Smart Mitochondrial Assay LIVE
Nanolive launches another ground-breaking tool in cell analysis: the Smart Mitochondrial AssayLIVE, the world’s first fully automated solution for noninvasive, quantitative assessment of mitochondrial dynamics. Created to accelerate drug discovery, the Smart...
Newsletter February: Unlocking the power of Nanolive’s holotomography
Welcome to the February edition of the AI for Live Cell Insights Newsletter, bringing you the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live...
Newsletter January: Breaking records and paving the way for future discoveries in car-t, mitochondria & lipid droplets research
Welcome to the January edition of the AI for Live Cell Insights Newsletter, bringing you the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live...